CoChat

Low-Dose IL-2 Attenuated Depression-like Behaviors and Pathological Changes through Restoring the Balances between IL-6 and TGF-β and between Th17 and Treg in a Chronic Stress-Induced Mouse Model of Depression

Open access
Huang, Chengyi, Zhang, Fucheng, Li, Peng, Song, Cai · 2022 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

Microglia activation, increased IL-6 and decreased TGF-β were found in depressed patients or in animal models of depression. IL-6 enhances T helper 17 cell differentiation, thereby causing an imbalance between Th17 and Treg cells, which induces neuroinflammation and neuronal dysfunction. However, whether imbalances between IL-6 and TGF-β and between Th17 and Treg occur in depression and whether depression can be improved upon restoring these imbalances are unknown. Treg promoter IL-2 (1500UI/0.1 mL/day) was used to treat a mouse model of depression induced by chronic unpredictable mild stress (CUMS). The behavior and concentrations of IL-6, TGF-β, Th17, IL-17A, IL-17Rc, Treg-related factors (helios and STAT5), astrocyte A1 phenotype S100β, microglia M1 phenotype Iba-1, indoleamine-2,3-dioxygenase (IDO) enzyme, corticosterone (CORT) and neurotransmitters were evaluated. When compared to controls, CUMS reduced sucrose preference, the number of entries into and the time spent in the open arms of the elevated plus maze and the exploration in the “open field”, while it increased the immobility time in tail suspension, which was ameliorated by IL-2 treatment. RoRα, S100β, IL-17A, IL-17Rc, IL-6, Iba-1, IDO enzyme and CORT concentrations were significantly increased, and Helios, FoxP3+, STAT5 and TGF-β were significantly decreased by CUMS, which were significantly attenuated by IL-2 when compared to the CUMS group. The NE, DA and 5-HT contents and those of their metabolites were decreased by CUMS, which returned to control levels after IL-2 treatment. The study demonstrated that imbalances between IL-6 and TGF-β and between Th17and Treg occurred in the hippocampus of the depression model. IL-2 attenuated depression- and anxiety-like behaviors and normalized the neurotransmitter concentration and the activity of the IDO enzyme, astrocytes and microglia through restoring both balances, but it did not decrease the CORT concentration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms232213856

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Possible mechanism by which low-dose IL-2 reversed CUMS-induced depression-like changes. IL-2R, interleukin-2 receptor; TGF-βR, transforming growth factor-β receptor; IL-6R, IL-6 receptor, IL-17Rc, IL-17 receptor c; ↑, level was increased; ↓, level was decreased; →, level was unchanged; solid line, known evidence; dotted line, hypothesis.
Figure 1 Possible mechanism by which low-dose IL-2 reversed CUMS-induced depression-like changes. IL-2R, interleukin-2 receptor; TGF-βR, transforming growth factor-β receptor; IL-6R, IL-6 receptor, IL-17Rc, IL-17 receptor c; ↑, level was increased; ↓, level was decreased; →, level was unchanged; solid line, known evidence; dotted line, hypothesis.CC BY · PubMed Central
Figure 2 Low-dose IL-2 attenuated anxiety- and depression-like behaviors induced by CUMS exposure. Percentage of sucrose consumption in the sucrose preference test (A). Locomotor activity (B), number of rearing (C), central zone entries (D) and defecation (E) in the open field test. Time spent (F) and number of entries (G) into the open arms of the elevated plus maze. Suspension immobility time in the tail suspension test (H) (n = 10–12). CT, control; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. **** p < 0.0001, ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.
Figure 2 Low-dose IL-2 attenuated anxiety- and depression-like behaviors induced by CUMS exposure. Percentage of sucrose consumption in the sucrose preference test (A). Locomotor activity (B), number of rearing (C), central zone entries (D) and defecation (E) in the open field test. Time spent (F) and number of entries (G) into the open arms of the elevated plus maze. Suspension immobility time in the tail suspension test (H) (n = 10–12). CT, control; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. **** p < 0.0001, ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.CC BY · PubMed Central
Figure 3 IL-2 normalized the concentration of monoamine neurotransmitters and their metabolites in the hippocampus and amygdala of CUMS mice. 5-HT (A), DA (C) and their turnovers (B,D) in the hippocampus; NE (E) and its turnover (F) in the amygdala (n = 6–8). CT, control; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.
Figure 3 IL-2 normalized the concentration of monoamine neurotransmitters and their metabolites in the hippocampus and amygdala of CUMS mice. 5-HT (A), DA (C) and their turnovers (B,D) in the hippocampus; NE (E) and its turnover (F) in the amygdala (n = 6–8). CT, control; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.CC BY · PubMed Central
Figure 4 IL-2 reduced the mRNA and protein expression of central pro-inflammatory factors and IL-17A receptor in the mouse hippocampus after CUMS exposure. IL-6 (A,D), IL-17A (B,E), IL-17Rc (C,F) and TGF-β (G) (n = 3–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.
Figure 4 IL-2 reduced the mRNA and protein expression of central pro-inflammatory factors and IL-17A receptor in the mouse hippocampus after CUMS exposure. IL-6 (A,D), IL-17A (B,E), IL-17Rc (C,F) and TGF-β (G) (n = 3–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.CC BY · PubMed Central
Figure 5 IL-2 restored the mRNA and protein expression of Th17 and Treg cell transcription factors in the hippocampus of CUMS mice. Th17 transcription factor RoRα (A,D), Treg transcription factor FoxP3+ (B,E), STAT5 (C,F) and Helios (G,H) in the hippocampus (n = 4–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.
Figure 5 IL-2 restored the mRNA and protein expression of Th17 and Treg cell transcription factors in the hippocampus of CUMS mice. Th17 transcription factor RoRα (A,D), Treg transcription factor FoxP3+ (B,E), STAT5 (C,F) and Helios (G,H) in the hippocampus (n = 4–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. * p < 0.05 vs. CT; # p < 0.05, ## p < 0.01 vs. CUMS.CC BY · PubMed Central
Figure 6 IL-2 attenuated the increased expression of microglia M1 phenotype marker Iba-1 (A), astrocyte A1 phenotype marker S100β (B) and IDO enzyme (C) in the hippocampus in the CUMS group (n = 6–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05 vs. CUMS.
Figure 6 IL-2 attenuated the increased expression of microglia M1 phenotype marker Iba-1 (A), astrocyte A1 phenotype marker S100β (B) and IDO enzyme (C) in the hippocampus in the CUMS group (n = 6–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01, * p < 0.05 vs. CT; # p < 0.05 vs. CUMS.CC BY · PubMed Central
Figure 7 IL-2 did not significantly decrease the corticosterone concentration in the serum of CUMS mice (n = 6–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01 vs. CT.
Figure 7 IL-2 did not significantly decrease the corticosterone concentration in the serum of CUMS mice (n = 6–8). CT, control group; CUMS, CUMS group; CUMS+IL-2, CUMS exposure with IL-2 treatment. ** p < 0.01 vs. CT.CC BY · PubMed Central
Figure 8 The correlations among different parameters were analyzed. Correlations between immobility time and NE or 5-HT (A), between IL-6 and TGF-β or IL-17A (B), between IL-17A and behaviors (C), between IL-6/TGFβ and behaviors (D), between Th17/Treg and behaviors (E), between Helios and behaviors (F) and between 5-HT and Th17/Treg or Helios (G).
Figure 8 The correlations among different parameters were analyzed. Correlations between immobility time and NE or 5-HT (A), between IL-6 and TGF-β or IL-17A (B), between IL-17A and behaviors (C), between IL-6/TGFβ and behaviors (D), between Th17/Treg and behaviors (E), between Helios and behaviors (F) and between 5-HT and Th17/Treg or Helios (G).CC BY · PubMed Central
Figure 9 Experimental procedures. CUMS, chronic unpredictable mild stress; SPT, sucrose preference; OFT, open field; EPM, elevated plus maze; TST, tail suspension tests; HPLC, high-performance liquid chromatography; qPCR, quantitative real-time polymerase chain reaction; ELISA, Enzyme-linked immunosorbent assay; WB, Western blot.
Figure 9 Experimental procedures. CUMS, chronic unpredictable mild stress; SPT, sucrose preference; OFT, open field; EPM, elevated plus maze; TST, tail suspension tests; HPLC, high-performance liquid chromatography; qPCR, quantitative real-time polymerase chain reaction; ELISA, Enzyme-linked immunosorbent assay; WB, Western blot.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Delgado, 2000, Depression: The case for a monoamine deficiency, J. Clin. Psychiatry, 61, 7

Cited by

See all 65

Metadata

Authors
Huang, C., Zhang, F., Li, P., & Song, C.
Affiliations
  • Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China
  • Guangdong Ocean University (CN)
  • Guangdong Medical College (CN)
Corresponding author
Song, Cai
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-11-10
Volume
23
Issue
22
Pages
13856
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4308865983
Cited by
65
References
50
Citations by year
2026: 9 · 2025: 19 · 2024: 25 · 2023: 11 · 2022: 1
FWCI
4.87
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of Guangdong Province (2021A1515011579, GJHZ20190823111414825, 2021A05046)
  • Science and Technology Plan (International Cooperative Research) Project of Shenzhen (2021A1515011579, GJHZ20190823111414825, 2021A05046)
  • Science and Technology Project of Zhanjiang (2021A1515011579, GJHZ20190823111414825, 2021A05046)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
IL-2 therapy, depression, chronic unpredictable mild stress, interleukin-6, TGF-beta, Th17/Treg imbalance, neuroinflammation, microglial activation, indoleamine 2,3-dioxygenase, corticosterone, neurotransmitters, hippocampus, anxiety-like behavior, neuroimmune regulation
MeSH terms
Animals, Corticosterone, Depression, Disease Models, Animal, Interleukin-2, Interleukin-6, Transforming Growth Factor beta, Interleukin-12, Interleukin-17, T-Lymphocytes, Regulatory, STAT5 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-Dose IL-2 Attenuated Depression-like Behaviors and Pathological Changes through Restoring the Balances between IL-6 and TGF-β and between Th17 and Treg in a Chronic Stress-Induced Mouse Model of Depression. https://app.cochat.ai/papers/10.3390/ijms232213856
The paper
Huang, C., Zhang, F., Li, P., & Song, C. (2022). Low-Dose IL-2 Attenuated Depression-like Behaviors and Pathological Changes through Restoring the Balances between IL-6 and TGF-β and between Th17 and Treg in a Chronic Stress-Induced Mouse Model of Depression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms232213856

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.